The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Drug Eluting Nylon Balloon Catheter market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Drug Eluting Nylon Balloon Catheter
The report offers actionable and valuable market insights of Drug Eluting Nylon Balloon Catheter. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Drug Eluting Nylon Balloon Catheter Market across various industries and regions.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=146
The global market for drug eluting balloon catheters is anticipated to progress at an impressive CAGR of 18% over the next ten years. This analysis has been performed by skilled analysts at Fact.MR, a market research and competitive intelligence provider, also reveals that demand for drug eluting balloon catheters comprises 20% share in the overall balloon catheters market at present. As per the study, the global drug eluting balloon catheter market is expected to be worth US$ 5.2 Bn by the end of 2031, with coronary artery disease drug eluting balloon catherization holding a mammoth 80% market share.
| Global Market Value in 2021 | US$ 1 Bn |
| CAGR (2021-2031) | 18% |
| Forecasted Market Value for 2031 | US$ 5.2 Bn |
| Dominant Market | Europe |
The scope of Fact.MR’s report is to analyze the global drug-eluting balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global drug-eluting balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to medical devices.
This newly published and insightful report sheds light on Market Insights of Drug Eluting Nylon Balloon Catheter, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Drug Eluting Nylon Balloon Catheter Market.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=146
MaKey Segments of Drug Eluting Balloon Catheter Industry Surveyrket Taxonomy
· By Indication:
-
- Coronary Artery Disease Drug Eluting Balloon Catheters
- Peripheral Vascular Disease Drug Eluting Balloon Catheters
· By End User:
-
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
· By Raw Material:
-
- Polyurethane Drug Eluting Balloon Catheters
- Nylon Drug Eluting Balloon Catheters
- Others
Competitive Landscape
Research in the drug eluting balloon catheter space by key players is anticipated bolster development and sales of more precise and efficient drug eluting balloon catheters.
- In February 2021, L2Mtech GmbH was awarded its first CE mark on six products. This marks a milestone in the company’s history and proves the efficacy and safety of its innovative cardiovascular and endovascular applications. The company is planning to commercially launch the products with the CE mark recognition.
- In June 2020, iVascular SLU, a medical device company, announced the global launch of its novel coronary artery drug-coated balloon. The product – Essential Pro – has several improvements from its predecessor.
- In March 2021, MedAlliance announced that it had received FDA approval for its drug-eluting coronary balloon. The product is called the Selution SLR sustained limus release drug-eluting balloon catheter. It received a go-ahead for its design, which improved luminal diameter in individuals affected with atherosclerotic lesions.
Increasing prevalence of cardiovascular diseases has created massive demand for related treatments. Cardiology intervention procedures have grown in popularity as well as their effectiveness has substantially been accepted across the globe. Focus on healthcare is more prominent than ever before due to the shortcomings that were noticed amidst the COVID-19 pandemic. Favorable reimbursement policies by health insurance providers and rising geriatric population are also factors that are set to propel demand for drug eluting balloon catheters.
However, risk of infection through the collapse of balloon catheters is expected to restrain market growth to some extent. This is being addressed as next-generation drug eluting balloon catheters are being researched and launched.
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/146
Key Takeaways from Market Study
- Drug eluting balloon catheter market expected to be worth US$ 5.2 Bn by 2031.
- Demand is anticipated to increase at impressive CAGR of 18%.
- Europe estimated to dominate global market in terms of market share.
- High cost and risk of infections expected to hinder demand for drug eluting balloon catheters.
- U.K market is anticipated to rise at astronomical CAGR of around 20% over next ten years.
- Surging instances of cardiovascular diseases, rising geriatric population, and attractive reimbursement policies by healthcare insurance providers are major factors driving sales.
“Increasing research & development by drug eluting balloon catheter manufacturers is anticipated to favor the industry in terms of demand and sales,” says a Fact.MR analyst.
List of Tables
TABLE 1 Global Drug Eluting Balloon Catheter Market Value (US$ Mn), 2016-2020
TABLE 2 Global Drug Eluting Balloon Catheter Market Value (US$ Mn), 2021-2031
TABLE 3 Global Drug Eluting Balloon Catheter Market Value (US$ Mn) and Y-o-Y, 2015-2031
TABLE 4 Global Coronary Artery Disease Segment Value (US$ Mn), By Region 2016-2020
TABLE 5 Global Coronary Artery Disease Segment Value (US$ Mn), By Region 2021-2031
List of Figures
FIG. 1 Global Drug Eluting Balloon Catheter Market Value (US$ Mn), 2016-2020
FIG. 2 Global Drug Eluting Balloon Catheter Market Value (US$ Mn) Forecast, 2021-2031
FIG. 3 Global Drug Eluting Balloon Catheter Market Value (US$ Mn) and Y-o-Y, 2015-2031
FIG. 4 Global Coronary Artery Disease Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 5 Global Coronary Artery Disease Segment Market Value (US$ Mn) By Region, 2021-2031
Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/
Key Question answered in the survey of Drug Eluting Nylon Balloon Catheter market report:
- Sales and Demand of Drug Eluting Nylon Balloon Catheter
- Growth of Drug Eluting Nylon Balloon Catheter Market
- Market Analysis of Drug Eluting Nylon Balloon Catheter
- Market Insights of Drug Eluting Nylon Balloon Catheter
- Key Drivers Impacting the Drug Eluting Nylon Balloon Catheter market
- Which are the Key drivers impacted by Drug Eluting Nylon Balloon Catheter market
- Restraints Shaping Market Growth
- Market Survey of Drug Eluting Nylon Balloon Catheter
More Valuable Insights on Drug Eluting Nylon Balloon Catheter Market
Fact.MR, in its new report, offers an unbiased Market Analysis of Drug Eluting Nylon Balloon Catheter, Sales and Demand of Drug Eluting Nylon Balloon Catheter, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.
Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031
Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031
Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
